Literature DB >> 25600022

Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma.

Myong Kim1, Kyung Chul Moon2, Woo Suk Choi1, Chang Wook Jeong1, Cheol Kwak1, Hyeon Hoe Kim1, Ja Hyeon Ku3,4.   

Abstract

PURPOSE: To determine the utility of systemic inflammatory response and develop a model based on serum inflammatory indices to aid prognostication in patients with upper urinary tract urothelial carcinoma (UTUC).
METHODS: The study population comprised 277 patients with non-metastatic UTUC who underwent nephroureterectomy between 1999 and 2010. Multivariate survival analysis was performed using Cox's proportional hazards model, and a new model was developed to predict recurrence-free (RFS) and disease-specific survival (DSS). The factors considered, in relation to systemic inflammatory responses, were as follows: albumin, white blood cell count, neutrophil count, lymphocyte count, red blood cell count, serum creatinine level, platelet count, prognostic nutritional index, platelet/lymphocyte ratio, neutrophil/lymphocyte ratio (NLR), and derived NLR.
RESULTS: The final model consisted of bladder cuffing, pathologic T stage, lymphovascular invasion, and derived NLR. The bootstrap-concordance indices of the model were 0.778 [95 confidence interval (CI) 0.730-0.826] for RFS and 0.802 (95 % CI 0.752-0.851) for DSS, respectively, and integrated area under the curve value for time to RFS and DSS for patients was 0.738 and 0.760, respectively. When we generated calibration curves, the nomograms were reasonably calibrated.
CONCLUSIONS: Derived NLR may be used in combination with conventional staging techniques and other clinicopathological parameters to improve the prediction of survival in patients with UTUC.

Entities:  

Keywords:  Inflammation; Nephroureterectomy; Prognosis; Survival; Ureter; Urothelial carcinoma

Mesh:

Year:  2015        PMID: 25600022     DOI: 10.1007/s00345-015-1484-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  32 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.

Authors:  G Kasymjanova; N MacDonald; J S Agulnik; V Cohen; C Pepe; H Kreisman; R Sharma; D Small
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

3.  Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

Authors:  Hsin-Yuan Hung; Jinn-Shiun Chen; Chien Yuh Yeh; Chung-Rong Changchien; Reiping Tang; Pao-Shiu Hsieh; Wen-Sy Tasi; Jeng-Fu You; Yau-Tong You; Chung-Wei Fan; Jeng-Yi Wang; Jy-Ming Chiang
Journal:  Int J Colorectal Dis       Date:  2011-04-09       Impact factor: 2.571

4.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

5.  Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer.

Authors:  Paul Glen; Nigel B Jamieson; Donald C McMillan; Ross Carter; Clem W Imrie; Colin J McKay
Journal:  Pancreatology       Date:  2006-07-13       Impact factor: 3.996

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.

Authors:  Giacomo Novara; Vincenzo De Marco; Fedra Gottardo; Orietta Dalpiaz; Vianney Bouygues; Antonio Galfano; Guido Martignoni; Jean Jacques Patard; Walter Artibani; Vincenzo Ficarra
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.

Authors:  Colin H Richards; Campbell S D Roxburgh; Mark T MacMillan; Sanad Isswiasi; Ewen G Robertson; Graeme K Guthrie; Paul G Horgan; Donald C McMillan
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Authors:  M J Proctor; D C McMillan; D S Morrison; C D Fletcher; P G Horgan; S J Clarke
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

View more
  22 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Can body mass index predict survival outcomes in patients treated with radical nephroureterectomy for upper-tract urothelial carcinoma?

Authors:  Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Int Urol Nephrol       Date:  2015-07-03       Impact factor: 2.370

3.  Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.

Authors:  Hyung Suk Kim; Ja Hyeon Ku; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim
Journal:  World J Urol       Date:  2015-10-23       Impact factor: 4.226

Review 4.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

5.  Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?

Authors:  Haci Ibrahim Cimen; Fikret Halis; Hasan Salih Saglam; Ahmet Gokce
Journal:  Int Braz J Urol       Date:  2017 Jan-Feb       Impact factor: 1.541

6.  Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.

Authors:  Shuiqing Wu; Qi Wan; Ran Xu; Xuan Zhu; Haiqing He; Xiaokun Zhao
Journal:  Oncotarget       Date:  2017-09-22

7.  The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.

Authors:  Dong-Yang Li; Xuan-Yu Hao; Tian-Ming Ma; Hui-Xu Dai; Yong-Sheng Song
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

8.  Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Xin Song; Gui-Ming Zhang; Xiao-Cheng Ma; Lei Luo; Bin Li; Dong-Yue Chai; Li-Jiang Sun
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147

Review 9.  Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer.

Authors:  Hyung Suk Kim; Ja Hyeon Ku
Journal:  Dis Markers       Date:  2016-01-05       Impact factor: 3.434

10.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.